You can choose the size of the video you would like to embed below. Next, copy the embed code that is available in the box below. Paste this code on to your website to display the video.
If you experience problems embedding videos, please contact us.
The Wall Street Journal
May 12, 2014 AT 10:38 AM
Allergan formally rejected the $46 billion unsolicited takeover bid made by Valeant Pharmaceuticals, saying the proposal substantially undervalues the Botox maker. Dana Mattioli joins MoneyBeat. Photo: AP.